GST polymorphisms are associated with hepatocellular carcinoma risk in Chinese population

World Journal of Gastroenterology

Volumn 17, Issue 27, 2011, Pages 3248-3256

  Yu, Lei ^a   Wang, Chun Yu ^b   Xi, Bo ^c   Sun, Lei ^a   Wang, Ruo Qi ^d   Yan, Yin Kun ^e   Zhu, Li Ying ^a  

^a HARBIN MEDICAL UNIVERSITY   (China)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c SHANDONG UNIVERSITY   (China)

^d YOUJIANG MEDICAL COLLEGE FOR NATIONALITIES   (China)

^e CAPITAL INSTITUTE OF PEDIATRICS   (China)

Author keywords

GSTM1; GSTT1; Hepatocellular carcinoma; Liver cancer; Polymorphism

Indexed keywords

GLUTATHIONE TRANSFERASE M1; GLUTATHIONE TRANSFERASE T1;

ARTICLE; CHINA; CONTROLLED STUDY; DATA BASE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENOTYPE; HUMAN; INCIDENCE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MEDLINE; META ANALYSIS; PUBLISHING; RISK; SENSITIVITY ANALYSIS; WEB BROWSER;

EID: 80051490624     PISSN: 10079327     EISSN: None     Source Type: Journal    
DOI: 10.3748/wjg.v17.i27.3248     Document Type: Article

References (69)

1. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics, 2010. CA Cancer J Clin. 2010;60:277-300.
2. Jemal A, Center MM, DeSantis C, Ward EM.Global patterns of cancer incidence and mortality rates and trends. Cancer Epidemiol Biomarkers Prev. 2010;19:1893-1907.
3. Ward E, Jemal A, Cokkinides V, Singh GK, Cardinez C, Ghafoor A, Thun M. Cancer disparities by race/ethnicity and socioeconomic status. CA Cancer J Clin. 2004;54:78-93.
4. McCracken M, Olsen M, Chen MS, Jemal A, Thun M, Cokkinides V, Deapen D, Ward E. Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities. CA Cancer J Clin. 2007;57:190-205.
5. Brechot C, Kremsdorf D, Soussan P, Pineau P, Dejean A, Paterlini-Brechot P, Tiollais P. Hepatitis B virus (HBV)-related hepatocellular carcinoma (HCC): molecular mechanisms and novel paradigms. Pathol Biol (Paris). 2010;58:278-287.
6. Wild CP, Law GR, Roman E. Molecular epidemiology and cancer: promising areas for future research in the post-genomic era. Mutat Res. 2002;499:3-12.
7. Schütte K, Bornschein J, Malfertheiner P. Hepatocellular carcinoma-epidemiological trends and risk factors. Dig Dis. 2009;27:80-92.
8. Wang JS, Groopman JD. DNA damage by mycotoxins. Mutat Res. 1999;424:167-181.
9. Chen PJ, Chen DS. Hepatitis B virus infection and hepatocellular carcinoma: molecular genetics and clinical perspectives. Semin Liver Dis. 1999;19:253-262.
10. Kew MC. Synergistic interaction between aflatoxin B1 and hepatitis B virus in hepatocarcinogenesis. Liver Int. 2003;23:405-409.
11. Seitz HK, Stickel F. Risk factors and mechanisms of hepatocarcinogenesis with special emphasis on alcohol and oxidative stress. Biol Chem. 2006;387:349-360.
12. Strange RC, Spiteri MA, Ramachandran S, Fryer AA. Glutathione-S-transferase family of enzymes. Mutat Res. 2001;482:21-26.
13. Parl FF. Glutathione S-transferase genotypes and cancer risk. Cancer Lett. 2005;221:123-129.
14. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene. 2006;25:1639-1648.
15. Hayes JD, Strange RC. Glutathione S-transferase polymorphisms and their biological consequences. Pharmacology. 2000;61:154-166.
16. Sun L, Xi B, Yu L, Gao XC, Shi DJ, Yan YK, Xu DJ, Han Q, Wang C. Association of glutathione S-transferases polymorphisms (GSTM1 and GSTT1) with senile cataract: a meta-analysis. Invest Ophthalmol Vis Sci. 2010;51:6381-6386.
17. White DL, Li D, Nurgalieva Z, El-Serag HB. Genetic variants of glutathione S-transferase as possible risk factors for hepatocellular carcinoma: a HuGE systematic review and meta-analysis. Am J Epidemiol. 2008;167:377-389.
18. Wang B, Huang G, Wang D, Li A, Xu Z, Dong R, Zhang D, Zhou W. Null genotypes of GSTM1 and GSTT1 contribute to hepatocellular carcinoma risk: evidence from an updated meta-analysis. J Hepatol. 2010;53:508-518.
19. Liu L, Zhuang W, Wang C, Chen Z, Wu XT, Zhou Y. Interleukin-8 -251 A/T gene polymorphism and gastric cancer susceptibility: a meta-analysis of epidemiological studies. Cytokine. 2010;50:328-334.
20. Wang R, Zhong B, Liu Y, Wang C. Association between alpha-adducin gene polymorphism (Gly460Trp) and genetic predisposition to salt sensitivity: a meta-analysis. J Appl Genet. 2010;51:87-94.
21. Zhang S, Wang C, Xi B, Li X. Association between the tumour necrosis factor-a-308G/A polymorphism and chronic obstructive pulmonary disease: an update. Respirology. 2011;16:107-115.
22. Garte S, Gaspari L, Alexandrie AK, Ambrosone C, Autrup H, Autrup JL, Baranova H, Bathum L, Benhamou S, Boffetta P. Metabolic gene polymorphism frequencies in control populations. Cancer Epidemiol Biomarkers Prev. 2001;10:1239-1248.
23. DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
24. MANTEL N, HAENSZEL W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst. 1959;22:719-748.
25. Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088-1101.
26. Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
27. Dong CH, Yu SZ, Chen GC, Zhao DM, Fu YP. Polymorphisms of GSTT1 and M1 genotypes and their effects on elevated aflatoxin exposure and increased risk of hepatocellular carcinoma. Zhongliu Fangzhi Yanjiu. 1997.pp.327-329.
28. Dong CH, Yu SZ, Chen GC, Zhao DM, Hu Y. Association of polymorphisms of glutathione S-transferase M1 and T1 genotypes with elevated aflatoxin and increased risk of primary liver cancer. Shijie Huaren Xiaohua Zazhi. 1998.pp.463-466.
29. Dong CH, Zi XL, Yu SZ, Han JS. Relationship between deletion of Glutathion S-transferase gene and susceptibility to primary hepatocellular carcinoma. Zhongguo Gonggong Weisheng Xuebao. 1997.pp.141-142.
30. Yu MW, Chiu YH, Chiang YC, Chen CH, Lee TH, Santella RM, Chern HD, Liaw YF, Chen CJ. Plasma carotenoids, glutathione S-transferase M1 and T1 genetic polymorphisms, and risk of hepatocellular carcinoma: independent and interactive effects. Am J Epidemiol. 1999;149:621-629.
31. Chen CJ, Yu MW, Liaw YF, Wang LW, Chiamprasert S, Matin F, Hirvonen A, Bell DA, Santella RM. Chronic hepatitis B carriers with null genotypes of glutathione S-transferase M1 and T1 polymorphisms who are exposed to aflatoxin are at increased risk of hepatocellular carcinoma. Am J Hum Genet. 1996;59:128-134.
32. Hsieh LL, Huang RC, Yu MW, Chen CJ, Liaw YF. L-myc, GST M1 genetic polymorphism and hepatocellular carcinoma risk among chronic hepatitis B carriers. Cancer Lett. 1996;103:171-176.
33. Yu MW, Chiu YH, Yang SY, Santella RM, Chern HD, Liaw YF, Chen CJ. Cytochrome P450 1A1 genetic polymorphisms and risk of hepatocellular carcinoma among chronic hepatitis B carriers. Br J Cancer. 1999;80:598-603.
34. Yu MW, Gladek-Yarborough A, Chiamprasert S, Santella RM, Liaw YF, Chen CJ. Cytochrome P450 2E1 and glutathione S-transferase M1 polymorphisms and susceptibility to hepatocellular carcinoma. Gastroenterology. 1995;109:1266-1273.
35. Yu MW, Lien JP, Chiu YH, Santella RM, Liaw YF, Chen CJ. Effect of aflatoxin metabolism and DNA adduct formation on hepatocellular carcinoma among chronic hepatitis B carriers in Taiwan. J Hepatol. 1997;27:320-330.
36. Yu MW, Yang SY, Chiu YH, Chiang YC, Liaw YF, Chen CJ. A p53 genetic polymorphism as a modulator of hepatocellular carcinoma risk in relation to chronic liver disease, familial tendency, and cigarette smoking in hepatitis B carriers. Hepatology. 1999;29:697-702.
37. Wu HL, Chen MN, Liu PX, Zhang RN. Relationship between GSTM1 gene polymorphism and genetic susceptibility to primary hepatocellular carcinoma. Shiyong Aizheng Zazhi. 2000.pp.463-465.
38. Sun CA, Wang LY, Chen CJ, Lu SN, You SL, Wang LW, Wang Q, Wu DM, Santella RM. Genetic polymorphisms of glutathione S-transferases M1 and T1 associated with susceptibility to aflatoxin-related hepatocarcinogenesis among chronic hepatitis B carriers: a nested case-control study in Taiwan. Carcinogenesis. 2001;22:1289-1294.
39. Zhu WC, Chen Q, Luo CL, Chu XW, Wu M. Relationship study between gene polymorphism of CYP1A1, GSTM1 and genetic susceptibility of primary hepatocellular carcinoma. Zhongliu Fangzhi Zazhi. 2001.pp.572-574.
40. Chen SY, Wang LY, Lunn RM, Tsai WY, Lee PH, Lee CS, Ahsan H, Zhang YJ, Chen CJ, Santella RM. Polycyclic aromatic hydrocarbon-DNA adducts in liver tissues of hepatocellular carcinoma patients and controls. Int J Cancer. 2002;99:14-21.
41. Liu CZ, Bian JC, Jiang F, Shen FM. Genetic polymorphism of glutathion S-transferase M1, T1, P1 on susceptibility hepatocellular carcinoma. Zhongguo Gonggong Weisheng. 2002.pp.935-936.
42. Bian J, Shen F, Wang J, Chen G, Zhang B, Wu Y. [The mutation of deletion for glutathione S-transferase M1 gene in the tissue of hepatocellular carcinoma]. Zhonghua Yi Xue Yi Chuan Xue Za Zhi. 1999;16:171-173.
43. Hu Y, Shen FM. Association between GSTM1 gene polymorphism of primary hepatocellular carcinoma and mutation of p53 codon 249. Zhonghua Yixue Yichuanxue Zazhi. 1997.pp.76-78.
44. Bian JC, Shen FM, Shen L, Wang TR, Wang XH, Jiang F, Lu M, Liu CZ, Chen GD, Wang JB. Susceptibility to hepatocelluar carcinoma is associated with the null genotypes of GSTM1 and GSTT1. Zhonghua Xiaohua Zazhi. 1999.pp.87-90.
45. Bian JC, Shen FM, Shen L, Wang TR, Wang XH, Chen GC, Wang JB. Susceptibility to hepatocellular carcinoma associated with null genotypes of GSTM1 and GSTT1. World J Gastroenterol. 2000;6:228-230.
46. McGlynn KA, Hunter K, LeVoyer T, Roush J, Wise P, Michielli RA, Shen FM, Evans AA, London WT, Buetow KH. Susceptibility to aflatoxin B1-related primary hepatocellular carcinoma in mice and humans. Cancer Res. 2003;63:4594-4601.
47. London WT, Evans AA, Buetow K, Litwin S, McGlynn K, Zhou T, Clapper M, Ross E, Wild C, Shen FM. Molecular and genetic epidemiology of hepatocellular carcinoma: studies in China and Senegal. Princess Takamatsu Symp. 1995;25:51-60.
48. London WT, Evans AA, McGlynn K, Buetow K, An P, Gao L, Lustbader E, Ross E, Chen G, Shen F. Viral, host and environmental risk factors for hepatocellular carcinoma: a prospective study in Haimen City, China. Intervirology. 1995;38:155-161.
49. McGlynn KA, Rosvold EA, Lustbader ED, Hu Y, Clapper ML, Zhou T, Wild CP, Xia XL, Baffoe-Bonnie A, Ofori-Adjei D. Susceptibility to hepatocellular carcinoma is associated with genetic variation in the enzymatic detoxification of aflatoxin B1. Proc Natl Acad Sci U S A. 1995;92:2384-2387.
50. Li SP, Wu JZ, Ding JH, Gao CM, Cao HX, Zhou XF. Impact of genetic polymorphisms of glutathione S-transferaseT1, M1 on the risk of primary hepatocellular carcinoma in alchohol drinkers. Shiyong Aizheng Zazhi. 2004.pp.229-232.
51. Chen CC, Yang SY, Liu CJ, Lin CL, Liaw YF, Lin SM, Lee SD, Chen PJ, Chen CJ, Yu MW. Association of cytokine and DNA repair gene polymorphisms with hepatitis B-related hepatocellular carcinoma. Int J Epidemiol. 2005;34:1310-1318.
52. Yu MW, Yang SY, Pan IJ, Lin CL, Liu CJ, Liaw YF, Lin SM, Chen PJ, Lee SD, Chen CJ. Polymorphisms in XRCC1 and glutathione S-transferase genes and hepatitis B-related hepatocellular carcinoma. J Natl Cancer Inst. 2003;95:1485-1488.
53. Deng ZL, Wei YP, Ma Y. Polymorphism of glutathione S-transferase mu 1 and theta 1 genes and hepatocellular carcinoma in southern Guangxi, China. World J Gastroenterol. 2005;11:272-274.
54. Ma Y, Wei YP, Deng ZL. GSTM1 gene polymorphisms of hepatocellular carcinoma from aflatoxin B1 high contaminated area in Guangxi, China. Aizheng. 2000.pp.868-870.
55. Deng Z, Wei Y, Ma Y. [Glutathione-S-transferase M1 genotype in patients with hepatocellular carcinoma]. Zhonghua Zhong Liu Za Zhi. 2001;23:477-479.
56. Wei YP, Deng ZL, Ma Y. Genetic polymorphisms of Glutathione S-transferase M1 and T1 and the risk of hepatocellular carcinoma. Zhongliu. 2003.pp.464-466.
57. Deng ZL, Wei YP, Ma Y. Genetic deletion of GSTM1 and GSTT1 detoxicated enzymes in relation to hepatocellular carcinoma in Guangxi. Guangxi Kexue. 2005.pp.55-57.
58. Guo HY, Bian JC, Jiang F, Wang QM, Zhang ZM, Fan WW, Wang QJ, Zhu X, Tang BM. The null genotypes of GSTM1 and GSTT1 and the genetic susceptibility of primary liver cancer in Luoyang, China. Zhongliu. 2005.pp.58-61.
59. He SJ, Qin JR, Gu YY, Zhong WG, Su SG. Analysis of GSTM1, GSTT1 polymorphisms in liver cancer patients. Guangxi Yike Daxue Xuebao. 2005.pp.875-877.
60. He SJ, Qin JR, Gu YY, Zhong WG, Su SG. Relationship between polymorphisms of phase II metabolic genes and the susceptibility to hepatocellular carcinoma in Guangxi. Shiyong Aizheng Zazhi. 2004.pp.460-462, 473.
61. He SJ, Gu YY, Liao ZH. The relationship between the susceptibility to primary liver cancer and GSTM1 polymorphism, cigarette smoking and alcohol drinking. Guangxi Yike Daxue Xuebao. 2008.pp.567-568.
62. Long XD, Ma Y, Wei YP, Deng ZL. [Study on the detoxication gene gstM1-gstT1-null and susceptibility to aflatoxin B1 related hepatocellular carcinoma in Guangxi]. Zhonghua Liu Xing Bing Xue Za Zhi. 2005;26:777-781.
63. Long XD, Ma Y, Wei YP, Deng ZL. [A study about the association of detoxication gene GSTM1 polymorphism and the susceptibility to aflatoxin B1-related hepatocellular carcinoma]. Zhonghua Gan Zang Bing Za Zhi. 2005;13:668-670.
64. Ma DL, Chen YX, Li Y, Zhao HT, Xie XM. Glutathione-S-transferase M1 and T1 polymorphisms (deficiency) and susceptibility to liver cancer in hepatitis B surface antigen positive (HBsAg positive) population. Guangxi Yixue. 2005.pp.656-657.
65. Zhang YC, Deng CS, Zhu YQ. Study on genetic polymorphisms of xenobiotica metabolizing enzymes in hepatitis B virus-associated hepatic diseases. Wenzhou Yixueyuan Xuebao. 2005.pp.464-467.
66. Zhu MH, Chen XH, Zhou LF. [Association of genetic polymorphisms in glutathione S-transferases M1 with hepatitis beta-related hepatocellular carcinoma]. Zhejiang Da Xue Xue Bao Yi Xue Ban. 2005;34:126-130.
67. Long XD, Ma Y, Wei YP, Deng ZL. The polymorphisms of GSTM1, GSTT1, HYL1*2, and XRCC1, and aflatoxin B1-related hepatocellular carcinoma in Guangxi population, China. Hepatol Res. 2006;36:48-55.
68. Yang ZG, Xie YA, Kuang ZP, Luo XL, Zhang WM, Leng CH. Relationship between genetic polymorphisms of glutathione-S-transferase M1, T1 genes and susceptibility to hepatocellular carcinoma in population of Fusui District of Guangxi Zhuang Autonomous Region. Zhonghua Zhongliu Fangzhi Zazhi. 2009.pp.970-975.
69. Liu ZG, Wei YP, Ma Y, Deng ZL. Population with GSTT1 gene deletion and the relationship to hepatocellular carcinoma from Guangxi. Guangxi Yike Daxue Xuebao. 2003.pp.161-163.